Overview

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

Status:
Recruiting

Trial end date:
2027-06-01

Target enrollment:

Participant gender:

Summary

This trial is a randomized study to evaluate and compare two doses of the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

SpyGlass Pharma, Inc.

Treatments:

Bimatoprost
Ophthalmic Solutions
Timolol